
Medistep Healthcare is engaged in the trading and manufacturing of pharmaceutical, nutraceutical, surgical, and intimate care products. The business model follows a B2B structure, catering to retail pharmacies, medical practitioners, and healthcare facilities. As of FY25, manufacturing contributed 26.51% to operational revenue, while trading activities contributed 73.49%. Product-wise, intimate care and hygiene products remained the largest revenue contributor with a combined share of over 93.51%. The company operates out of a 371.61 sq. mtr. manufacturing facility in Kheda, Gujarat. Medistep primarily serves the western Indian market, with 100% of FY25 revenue originating from Gujarat.
Bidding starts for all investor categories
Last day to place your bid
Share allotment finalised
Refunds credited for non-allottees
Allotted shares credited to demat account
Shares list on NSE / BSE
Post-close dates are indicative as per SEBI T+3 listing framework and may change per registrar updates.
| Investor Type | Min Lots | Min Shares | Min Amount | Max Lots | Max Amount | Notes |
|---|---|---|---|---|---|---|
| Retail / Individual | 1 | 3000 | ₹129,000 | 1 | ₹129,000 | 1 lot only |
| HNI | 2 | 6000 | ₹258,000 | 2 | ₹258,000 | Min 2 lots |
| Category | Reservation | Shares Offered | Amount (₹ Cr) | Shares Bid | Subscribed | Allotment % |
|---|---|---|---|---|---|---|
| QIB | 50% | 1,860,465 | 8 | 0 | 0.00x | 100% |
| NII | 15% | 558,140 | 2.4 | 0 | 0.00x | 100% |
| Retail | 35% | 1,302,326 | 5.6 | 0 | 0.00x | 100% |
Retail is a lottery-based allotment when oversubscribed; QIB/NII get pro-rata. Probability ≈ 1 / subscription times (100% if under-subscribed).